End-Stage Renal Disease Perspective

 
 

  • Why I Recommend Hepatitis B Vaccination to All My Patients   New age-based hepatitis B vaccine recommendations and available vaccine products are reviewed by Dr Sandra Fryhofer.
  • Strangers Donating Kidneys: 'Important Contributions' Kidney donations from strangers have been increasing, but there is still need for more. Dr Divyanshu Malhotra reviews current programs and offers ways to increase 'Good Samaritan' donations.
  • ISN 2022 Read clinically focused news coverage of key developments from ISN 2022
  • Organ Transplantation: Unvaccinated Need Not Apply Outrage over the denial of transplant organs to the unvaccinated is an opportunity to educate people on the complexities of organ allocation, writes Melissa Walton-Shirley, channeling her inner Ted Lasso.
  • Should We Always Offer CPR? The case of an elderly unconscious patient prompts this doctor to question why CPR is the default strategy and brings to mind the hero of a Hemingway short story.
  • Racial Inequities in Offering New Technologies for Diabetes Dr Plotzker discusses inequities in prescribing advanced technology for patients with diabetes, noting that Black patients are least likely to have access and use these devices.
  • How a Low-Protein Diet Can Delay Dialysis The low-protein PLADO diet can boost the effects of medications and help preserve renal function.
  • Optimal Use of SGLT2 Inhibitors and GLP-1 Agonists In light of the vast benefits demonstrated by SGLT2 inhibitors and GLP-1 agonists, Dr Matthew Budoff highlights how cardiologists and preventive care physicians can optimize their use in patient care.
  • ERA-EDTA 2021 Read clinically focused news coverage of key developments from ERA-EDTA 2021
  • Palliative Care Update for Clinicians Timely initiation of palliative care services is a challenge, especially for those with noncancer diagnoses, but recent studies offer novel approaches to end-of-life care planning across settings.
  • ISN 2021 Read clinically focused news coverage of key developments from ISN 2021
  • Organ Harvesting's Troubled Past — and Complicated Present With the rise of organ transplantation came difficult ethical questions on race, economics, and the meaning of life.
  • NKF 2021 Read clinically focused news coverage of key developments from the virtual NKF 2021 Spring Clinical Meetings
  • SGLT2 Inhibitors in T1D: 'People Are Using Them Now'   Dr Anne Peters talks about what you need to know regarding off-label use of SGLT2 inhibitors in type 1 diabetes.
  • What You Don't Know About Beta-Blockers and Hemodialysis A new look at the literature turned up a finding that surprised this nephrologist.
  • Lawsuit: Doctor Leaked Private Information to Patient's Family Treating patients from the same family who live together can raise your risk for privacy violations.
  • Does Oxygenated Cold Perfusate Improve Transplant Outcomes? If ischemia is a barrier to organ preservation, will the addition of oxygen to cold preservation solutions improve renal transplant outcomes?
  • Which Antidiabetic Drug Class is Most Renoprotective? In a clash of the antidiabetic drug titans, which class demonstrates the most renoprotection?
  • ESC 2020 DAPA-CKD: SGLT2 Inhibitors 'The Beta-Blockers for the Kidneys'   Nephrologists Jennie Lin and Leslie Gewin discuss the effects of dapagliflozin in patients with CKD. How do the DAPA-CKD findings fit with the CREDENCE data on SGLT2 inhibitors?
  • The Kidney and COVID-19: What We Know so Far   Nephrologists Matthew Sparks and Samira Farouk, of the Freely Filtered podcast, discuss the kidney effects of COVID-19 -- what is and isn't clear in patients with and without preexisting kidney disease.